Filter
Sort
From Early Detection to Late Recognition, Issue 2
From Early Detection to Late Recognition, Issue 2

The continuing research into CFTR modulators has answered many questions but has raised many others. Such as: Is there a single specific algorithm app...

Expires: 10.06.2028
From Early Detection to Late Recognition, Issue 1
From Early Detection to Late Recognition, Issue 1

This issue focuses (explores strategies to improve) on improving cystic fibrosis (CF) detection across the lifespan, highlighting national consensus g...

Expires: 08.31.2028
Special Edition 2025, Issue 1
Special Edition 2025, Issue 1

Until the advent of highly effective CFTR modulator medications, cystic fibrosis was considered a pediatric disease, because most individuals did not...

Expires: 03.02.2027
Special Edition: eCysticFibrosis Review, Issue 2
Special Edition: eCysticFibrosis Review, Issue 2

Individuals with cystic fibrosis — adults as well infants and children — have long struggled to gain and maintain their weight. But how ha...

Expired: 12.22.2024
Special Edition: eCysticFibrosis Review, Issue 1
Special Edition: eCysticFibrosis Review, Issue 1

Cystic fibrosis and weight gain. For most of their lives, individuals with CF have struggled to gain weight and achieve BMI norms. For most, despite t...

Expired: 12.22.2024
CF Educational Resource Center
CF Educational Resource Center

The CF Educational Resource Center (CFERC) is an interactive online platform that delivers customized learning to meeting organizers based on educational needs identified by the CF community.

Issue 7
Issue 7

Cystic fibrosis and weight gain. For most of their lives, individuals with CF have struggled to gain weight and achieve BMI norms. For most, despite t...

Expired: 12.22.2024
Issue 8
Issue 8

Individuals with cystic fibrosis — adults as well infants and children — have long struggled to gain and maintain their weight. But how ha...

Expired: 12.22.2024
Issue 6
Issue 6

The advent of triple CFTR modulator therapy – ETI (elexacaftor/tezacaftor/ivacaftor) — poses a number of clinical questions. Are three age...

Expired: 09.13.2024
Issue 5
Issue 5

ETI — elexacaftor/tezacaftor/ivacaftor — is next-generation triple-combination CFTR modulator therapy. Its recent pivotal trials have show...

Expired: 08.22.2024
Issue 4
Issue 4

Managing pulmonary exacerbations in people with cystic fibrosis: is there high-grade evidence to support best practices? How helpful is the most curre...

Expired: 07.18.2024
Issue 3
Issue 3

Where’s the evidence about managing pulmonary exacerbations in people with cystic fibrosis? What actually defines an exacerbation? Do females an...

Expired: 07.18.2024
Issue 2
Issue 2

Race and ethnicity. How do they affect a patient’s ability to receive a timely and accurate cystic fibrosis diagnosis? How do the social determi...

Expired: 06.20.2024
Issue 1
Issue 1

BIPOC (Black, Indigenous, people of color): why is an accurate diagnosis of cystic fibrosis so often missed — or delayed, or misdiagnosed &mdash...

Expired: 05.11.2024
Issue 13
Issue 13

Pancreatic insufficiency. In children with CF, it’s been associated with delayed development and increased odds of developing severe lung diseas...

Expired: 03.30.2023
Issue 12
Issue 12

The effects of malnutrition in people with cystic fibrosis are critical concerns for patients and their health care providers. The condition is especi...

Expired: 01.08.2023